EPISODE #89 The Chemistry of Cannabis with Dr. Markus Roggen, CEO of Complex Biotech Discovery Vent скачать в хорошем качестве

EPISODE #89 The Chemistry of Cannabis with Dr. Markus Roggen, CEO of Complex Biotech Discovery Vent

On today’s show we’re joined by Dr. Markus Roggen CEO of Complex Biotech Discovery Ventures (CBDVL) - licensed cannabis research and development firm focusing on cannabis extraction optimisation, analytical testing, and chemical process development. Join us as we dive into the chemistry of cannabis, including the different ways in which cannabinoids can be extracted, why the ‘entourage effect’ needs to be redefined, and the role of fundamental cannabis research. → View full show notes and summary here: https://www.cannabis-conversation.com... About Dr. Markus Roggen Dr. Markus Roggen’s latest project, Complex Biotech Discovery Ventures, is a fundamental research laboratory and CRO for the cannabis and hemp industries. His research interests lie in the metabolite composition and behavior throughout the production cycle, extraction optimisation, and development of innovative therapeutic formulations. Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He then pursued his graduate degree in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. Dr. Roggen was awarded an DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla from 2013-2014.  He then entered the cannabis industry, at first as laboratory director for Davinci Laboratories of California, an analytical laboratory from 2014 to 2016. In 2016, he moved into an executive position overseeing production, R&D and process optimisation for OutCo, a vertically integrated cannabis company. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organisations. Positions include advisory positions at Bloom Automation, a cannabis robotics company, and former SAB member at MediPharm Labs, a Canadian LP, and co-chair of the NCIA Scientific Advisory Committee.